Back to UBS Group AG UBS Group AG

BLRXBLRX
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in BIOLINE RX LIMITED

UBS Group AG holds 101 shares of BLRX (BIOLINE RX LIMITED), worth $315 as of 2026-Q2. The position was decreased (-80.9% shares).

Current Value

$315

Current Shares

101

Total Value Change

+$105

Total Shares Change

+30

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
101
-80.9%
$3150.0%$3.12
0
2026-Q1
Decreased
529
-72.9%
$1,2170.0%$2.81
0
2025-Q4
Decreased
1,951
-69.5%
$5,4040.0%$2.87
0
2025-Q3
New
6,387
-
$24,1430.0%$3.76
29
2025-Q2
Exited
0
-100.0%
$00.0%$4.43
0
2025-Q1
New
71
-
$2100.0%$3.05
17

Other major holders of BLRX: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SIMPLEX TRADING, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used